Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contemporaneous Risk Factors for Visual Acuity in Non-Infectious Uveitis.
Pistilli M, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Kempen JH. Pistilli M, et al. Among authors: pujari ss. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1056-1063. doi: 10.1080/09273948.2020.1828493. Epub 2021 Feb 23. Ocul Immunol Inflamm. 2021. PMID: 33621148
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.
Kempen JH, Daniel E, Gangaputra S, Dreger K, Jabs DA, Kaçmaz RO, Pujari SS, Anzaar F, Foster CS, Helzlsouer KJ, Levy-Clarke GA, Nussenblatt RB, Liesegang T, Rosenbaum JT, Suhler EB. Kempen JH, et al. Among authors: pujari ss. Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55. doi: 10.1080/09286580701585892. Ophthalmic Epidemiol. 2008. PMID: 18300089
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.
Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Kaçmaz RO, et al. Am J Ophthalmol. 2008 Dec;146(6):828-36. doi: 10.1016/j.ajo.2008.06.019. Epub 2008 Aug 16. Am J Ophthalmol. 2008. PMID: 18708181 Free PMC article.
Azathioprine for ocular inflammatory diseases.
Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB. Pasadhika S, et al. Among authors: pujari ss. Am J Ophthalmol. 2009 Oct;148(4):500-509.e2. doi: 10.1016/j.ajo.2009.05.008. Epub 2009 Jul 1. Am J Ophthalmol. 2009. PMID: 19570522 Free PMC article.
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, Suhler EB, Thorne JE. Kempen JH, et al. Among authors: pujari ss. BMJ. 2009 Jul 3;339:b2480. doi: 10.1136/bmj.b2480. BMJ. 2009. PMID: 19578087 Free PMC article.
Cyclophosphamide for ocular inflammatory diseases.
Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS. Pujari SS, et al. Ophthalmology. 2010 Feb;117(2):356-65. doi: 10.1016/j.ophtha.2009.06.060. Epub 2009 Dec 6. Ophthalmology. 2010. PMID: 19969366 Free PMC article.
Mycophenolate mofetil for ocular inflammation.
Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH. Daniel E, et al. Among authors: pujari ss. Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2. doi: 10.1016/j.ajo.2009.09.026. Epub 2009 Dec 30. Am J Ophthalmol. 2010. PMID: 20042178 Free PMC article.
Ocular disease in patients with ANCA-positive vasculitis.
Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, Nussenblatt RB, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Suhler EB, Smith JR. Watkins AS, et al. Among authors: pujari ss. J Ocul Biol Dis Infor. 2009 Dec 12;3(1):12-19. doi: 10.1007/s12177-009-9044-4. J Ocul Biol Dis Infor. 2009. PMID: 20835396 Free PMC article.
High-dose intravenous corticosteroids for ocular inflammatory diseases.
Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH. Charkoudian LD, et al. Among authors: pujari ss. Ocul Immunol Inflamm. 2012 Apr;20(2):91-9. doi: 10.3109/09273948.2011.646382. Ocul Immunol Inflamm. 2012. PMID: 22409561 Free PMC article.
52 results